NVCT Stock Summary and Trading Ideas (Nuvectis Pharma | NASDAQ:NVCT)

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Nuvectis Pharma trades on the NASDAQ stock market under the symbol NVCT.

As of April 1, 2026, NVCT stock price declined to $7.64 with 21,447 million shares trading.

NVCT has a beta of 1.13, meaning it tends to be more sensitive to market movements. NVCT has a correlation of 0.14 to the broad based SPY ETF.

NVCT has a market cap of $202.40 million. This is considered a Small Cap stock.

In the last 3 years, NVCT traded as high as $18.65 and as low as $4.44.

The top ETF exchange traded funds that NVCT belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

NVCT has underperformed the market in the last year with a price return of -21.8% while the SPY ETF gained +18.5%. However, in the short term, NVCT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +1.2% vs -3.7% return in SPY. But in the last 2 weeks, NVCT shares have been beat by the market, returning -12.3% compared to an SPY return of -2.1%.

NVCT support price is $7.42 and resistance is $8.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVCT shares will trade within this expected range on the day.